Mechanistic studies have shown that HSP70 downregulation impedes cancer cell growth, migration, invasion in various types of cancer, including colorectal, urothelial, hepatocellular carcinoma, renal cell carcinoma, pancreatic and breast cancers (45–50). This evidence concerns the gene HSPA1A and breast carcinoma.